Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

A study of depressed individuals found that an eight‐week treatment with selective serotonin reuptake inhibitors (SSRIs) ...

According to the WHO, depression affects approximately 280 million people globally and has a strong relationship with ...

Fiancé star Larissa Dos Santos Lima has been diagnosed with major depressive disorder and is stepping away from social media. A rep for the reality star, 38, named Julia Dickson, announced the news on ...

The depression treatment market is experiencing steady growth, driven by rising mental health awareness, increasing prevalence of depression, and advancements in novel therapies. The market is ...

The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...

The following is a summary of “Comparative effectiveness of short-term psychodynamic psychotherapy and cognitive behavioral ...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) revealed the topline data from the Phase 2b study of SPN-820 in adults with ...